We've had pramlintide on the market for years, but we have this long-acting version that is in phase three clinical development
Crystal Broussard, MD, is a board-certified family physician and a Fellow of the American Board of Obesity Medicine
Weight loss was 6.0% (6.4 kg), 4.7% (5.0 kg), and 2.0% (2.2 kg) with liraglutide 3.0 mg, liraglutide 1.8 mg, and placebo, respectively
Doctors told India Today that as more women undergo obesity treatment and regain metabolic balance, many are unaware that their chances of conceiving can rise sharplysometimes immediatelyafter significant weight loss
There are currently no published clinical trials evaluating the safety or efficacy of compounded GLP-1 ODTs
Vomiting, severe diarrhea, or inability to keep fluids down requires medical advice